Cited by 44Bariatric Surgery and OutcomesAdipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Metabolic adaptations after bariatric surgery: Adipokines, myokines and hepatokines

Faramia, Justine, Ostinelli, Giada, Drolet-Labelle, Virginie, Picard, Frédéric, Tchernof, André·2020·Current Opinion in Pharmacology

Abstract

This review addresses the impact of bariatric surgery on the endocrine aspects of white adipose tissue, muscle and the liver. We describe literature supporting the notion that adipokines, myokines and hepatokines likely act in concert and drive many of the long-term metabolic improvements following surgery. Circulating adiponectin is increased while secretion of pro-inflammatory interleukins (1, 6 and 8) decreases, alongside leptin secretion. The metabolic improvements observed in the muscle might relate to reduction of myokines contributing to insulin resistance (including myostatin, brain-derived neurotrophic factor and fibroblast growth factor-21). Subject to exception, hepatokine secretion is generally increased (such as insulin-like growth factor-binding protein 2, adropin and sex hormone-binding globulin). In conclusion, bariatric surgery restores metabolic functions by enhancing the time-dependent secretion of anti-inflammatory, insulin-sensitizing and antilipemic factors. Further research is needed to understand the molecular mechanisms by which these factors may trigger the remission of obesity-related comorbidities following bariatric surgery.

Integrity signals

Registry

Crossref · 10.1016/j.coph.2020.06.005

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Organokines have specific associations with insulin resistance, diabetes mellitus, obesity, metabolic syndrome, and cardiovascular disease.

    “Therefore, they have specific associations with insulin resistance, diabetes mellitus, obesity, metabolic syndrome, and CVD [10].”
  • The network of adipokines, myokines, and hepatokines may have beneficial or non-beneficial effects on the genesis of various physiological disorders and their outcomes, such as DM2, obesity, metabolic syndrome, and CVD.

    “Far beyond understanding each adipokine, myokine, or hepatokine’s actions alone, it is important to underline that these cytokines act together in the body, forming a complex network of actions in different tissues, which may have beneficial or non-beneficial effects on the genesis of various physiological disorders, and their respective outcomes, such as DM2, obesity, metabolic syndrome, and CVD”
  • Adipokines, myokines, and hepatokines act together in the body, forming a complex network of actions in different tissues.

    “Far beyond understanding each adipokine, myokine, or hepatokine’s actions alone, it is important to underline that these cytokines act together in the body, forming a complex network of actions in different tissues, which may have beneficial or non-beneficial effects on the genesis of various physiological disorders, and their respective outcomes, such as DM2, obesity, metabolic syndrome, and CVD”

The citation lists haven’t been fetched yet

References 89 · Cited by 44

Authors
Faramia, J., Ostinelli, G., Drolet-Labelle, V., Picard, F., & Tchernof, A.
Affiliations
Institut universitaire de cardiologie et de pneumologie de Québec (CA)
Corresponding author
  • Picard, Frédéric
  • Tchernof, André
Venue
Current Opinion in Pharmacology
Publisher
Elsevier BV
Published
2020-06
Volume
52
Pages
67-74
ISSN
1471-4892 (ISSN-L)
OpenAlex
W3043222142
Cited by
44
References
89
Citations by year
2026: 4 · 2025: 11 · 2024: 7 · 2023: 6 · 2022: 9 · 2021: 4 · 2020: 3
FWCI
1.25
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Johnson & Johnson Medical Companies
  • Medtronic
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
bariatric surgery, adipokines, myokines, hepatokines, white adipose tissue, skeletal muscle, liver, adiponectin, leptin, interleukins, myostatin, brain-derived neurotrophic factor, FGF21, insulin resistance, IGFBP-2, adropin, sex hormone-binding globulin, anti-inflammatory factors, insulin sensitivity
MeSH terms
Adaptation, Physiological, Adipose Tissue, Humans, Liver, Obesity, Muscle, Skeletal, Bariatric Surgery, Adipokines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review